- Home
- RVNC vs NBY Comparison
RVNC vs NBY Comparison
Compare RVNC & NBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVNC
- NBY
- Stock Information
- Founded
- RVNC 1999
- NBY 2000
- Country
- RVNC United States
- NBY United States
- Employees
- RVNC N/A
- NBY N/A
- Industry
- RVNC Biotechnology: Pharmaceutical Preparations
- NBY
- Sector
- RVNC Health Care
- NBY
- Exchange
- RVNC Nasdaq
- NBY Nasdaq
- Market Cap
- RVNC 320.5M
- NBY 3.3M
- IPO Year
- RVNC 2014
- NBY 2007
- Fundamental
- Price
- RVNC $3.09
- NBY $0.53
- Analyst Decision
- RVNC Hold
- NBY Strong Buy
- Analyst Count
- RVNC 9
- NBY 1
- Target Price
- RVNC $8.45
- NBY $0.85
- AVG Volume (30 Days)
- RVNC 3.6M
- NBY 82.3K
- Earning Date
- RVNC 11-07-2024
- NBY 11-07-2024
- Dividend Yield
- RVNC N/A
- NBY N/A
- EPS Growth
- RVNC N/A
- NBY N/A
- EPS
- RVNC N/A
- NBY N/A
- Revenue
- RVNC $256,945,000.00
- NBY $13,844,000.00
- Revenue This Year
- RVNC $11.28
- NBY N/A
- Revenue Next Year
- RVNC $27.21
- NBY $26.04
- P/E Ratio
- RVNC N/A
- NBY N/A
- Revenue Growth
- RVNC 25.82
- NBY 15.40
- 52 Week Low
- RVNC $2.30
- NBY $0.36
- 52 Week High
- RVNC $9.75
- NBY $9.10
- Technical
- Relative Strength Index (RSI)
- RVNC 33.47
- NBY 39.55
- Support Level
- RVNC $3.06
- NBY $0.49
- Resistance Level
- RVNC $3.09
- NBY $0.58
- Average True Range (ATR)
- RVNC 0.11
- NBY 0.03
- MACD
- RVNC 0.02
- NBY -0.01
- Stochastic Oscillator
- RVNC 6.90
- NBY 36.27
About RVNC Revance Therapeutics Inc.
Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched a prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD platform. Its main products include DaxibotulinumtoxinA for Injection and DaxibotulinumtoxinA for Injection Aesthetics. The operating business segments are the Product and the Service Segment. The Products segment generates maximum revenue and is engaged in the research and development of aesthetic and therapeutic products.
About NBY NovaBay Pharmaceuticals Inc.
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically eyecare and skincare products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease. It has two reportable segments: Eyecare and Wound Care and Skincare.